CClinicalTrials.gg
Sign In
Status unknownNCT05614830Updated Nov 14, 2022

Effectiveness Taif University P. O. Box 11099 Taif 21944 Effectiveness of Dry Needling in Management of Myofacial Trigger Point

An interventional study of Dry needling , and usual physical therapy program in Myofacial Trigger Points, sponsored by Taif University. Status unknown. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-11-14.

Sponsored by Taif University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Nov 2022), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

myofascial pain syndrome is considered to be a chronic condition due to sensitive pressure points within the muscle recognized as trigger points

Generally the aim of this study will be :

  • To investigate the effectiveness of dry needling on trigger point in trapezius muscle
  • Evaluate the pain level before and after the applications of dry needling on trigger points
  • compare between the effects of dry needling and physical therapy exercise program
02

Conditions studied

  • Myofacial Trigger Points
03

In context

Lead sponsor

Taif University is the lead sponsor of 15 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Clinically active trigger point and expression of symptoms of neck pain in trapezius which had lasted for at least 3 months.
  • Having a pain level higher than 4 and lower than 8 on Visual Analogue Scale ( VAS )
  • Did not receive any other form of neck treatment during the previous month.

Exclusion criteria

Exclusion Criteria:

  • Presence of cardiopulmonary disease , the application process requires the subject to be in prone position to expose the area of treatment, this position is un-preferable for cardiopulmonary patients
  • History of neck surgery
  • Trigger point treatment in the last 30 days
  • Any contraindications for dry needling such as local infection, skin disease ,severe postural disorder , tumor , rheumatoid arthritis, cervical spine stenosis and bilateral upper extremity symptoms
  • pregnancy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Intervention group

    Other: Dry needling ,

  • Active comparator
    Control group

    Usual physical therapy protocol 4 sessions, two sessions per week each session will include a group of therapeutic exercises

    Other: usual physical therapy program

Interventions

  • OtherDry needling ,

    The intervention group will receive sessions of dry needling to relief myofacial pain on trapezius

  • Otherusual physical therapy program

    Therapeutic exercise

06

What researchers measure

Primary outcomes

  1. Pain level

    Will be determined using the visuals analogue scale (VAS)

    Time frame: 6 weeks

  2. Neck disability index

    questionnaire contains 10 items aiming to evaluate the limitation because of neck pain

    Time frame: 6 weeks

Secondary outcomes

  1. Depression

    Will be determined using the Beck's Depression Inventory ( BDI)

    Time frame: 6 weeks

  2. Neck Range of motion

    Will be measured using CROM

    Time frame: 6 weeks

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 14, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05614830
Lead sponsor
Taif University
Responsible party
Slwa Sami Alattar (Student, Taif University) — Principal investigator
First posted
Nov 14, 2022
Start date
Jan 2023 (estimated)
Primary completion
Jun 2023 (estimated)
Completion
Jun 2023 (estimated)
Last update
Nov 14, 2022

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Taif University

Start the discussion